<乌鸦传媒>Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplant Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients Nov 07, 2023
<乌鸦传媒>Novel Aldosterone Synthase Inhibitor Cuts Albuminuria in Phase II Trial Trial tested BI 690517 with and without empagliflozin Nov 06, 2023
<乌鸦传媒>ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Disease But ZENITH-CKD trial had to pivot to only using low-dose zibotentan due to fluid retention Nov 05, 2023
<乌鸦传媒>Heat and Cardiovascular Death; Time-Restricted Eating or Caloric Restriction in T2D Also in TTHealthWatch: managing nasal airway obstruction Nov 04, 2023 podcast
<乌鸦传媒>Year in Review: Type 2 Diabetes New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
<乌鸦传媒>Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deaths Health news and commentary from around the Web gathered by 乌鸦传媒 staff Oct 30, 2023
<乌鸦传媒>Another Study Highlights Metformin's Dementia Protection Properties Association appeared irrespective of HbA1c level Oct 25, 2023
<乌鸦传媒>Counterfeit Ozempic; Mary Lou Retton Discharged; No Such Thing as Free Will? Health news and commentary from around the Web gathered by 乌鸦传媒 staff Oct 24, 2023
<乌鸦传媒>CVS Pulls Phenylephrine Cold Meds; Doc's Murder/Suicide; Red Meat and Diabetes Health news and commentary from around the Web gathered by 乌鸦传媒 staff Oct 20, 2023
<乌鸦传媒>Highly Potent Statin Stands Out for Diabetes, Cataract Risks Head-to-head comparison of rosuvastatin vs atorvastatin in LODESTAR trial Oct 19, 2023
<乌鸦传媒>Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Change Trial participants lost over a fifth of their body weight atop diet, exercise-induced losses Oct 16, 2023
<乌鸦传媒>Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
<乌鸦传媒>Inflammation of the Aorta; Afib in the Hospital Also in TTHealthWatch: standards for osteoporosis screening and HbA1c in premenopausal women Oct 07, 2023 podcast
<乌鸦传媒>CPAP Turns in Mixed Results for Patients With Diabetic Eye Disease Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
<乌鸦传媒>Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
<乌鸦传媒>Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetes The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
<乌鸦传媒>Hybrid Closed-Loop Insulin System for T1D Safe, Effective During Pregnancy However, no FDA-approved systems have a pregnancy indication yet Oct 05, 2023
<乌鸦传媒>Mixed Bag for Early Metformin in Gestational Diabetes EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
<乌鸦传媒>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<乌鸦传媒>Pharmacists Improve Diabetes Control for Hispanic Patients Medication-adjustment recommendations were linked to some improvements in type 2 diabetes Oct 02, 2023
<乌鸦传媒>FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
<乌鸦传媒>Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugs Lower risk compared with DPP-4 inhibitors, and聽similar risk versus GLP-1 receptor agonists Sep 26, 2023
<乌鸦传媒>FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetes We haven't seen "the best version of this device," said panel member Sep 22, 2023
<乌鸦传媒>Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise. Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
<乌鸦传媒>Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Say Privacy policies, terms of sale often are unclear Sep 18, 2023
<乌鸦传媒>Keto for Kids With Diabetes Carries Risk, AAP Warns American Academy of Pediatrics outlines policy for low-, very low-carbohydrate diets Sep 18, 2023
<乌鸦传媒>Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
<乌鸦传媒>Mask Attack Leaves Actor Blind; Diabetes Risk in Night Owls; U.S. Blood Shortage Health news and commentary from around the Web gathered by 乌鸦传媒 staff Sep 12, 2023
<乌鸦传媒>When Temps Rise, So Do Medical Risks. Should Docs and Nurses Talk More About Heat? "This is not your grandmother's heat," says policy expert Sep 10, 2023
<乌鸦传媒>Low-Dose Semaglutide Can Ease Insulin Need in Early T1D, Small Series Shows All 10 patients were able to eliminate prandial insulin use within 3 months Sep 06, 2023
<乌鸦传媒>Case Grows for SGLT2 Inhibitors as Gout Treatment Large cohort study shows expansive benefits Aug 28, 2023
<乌鸦传媒>SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guideline Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more Aug 25, 2023
<乌鸦传媒>Should People Without Diabetes Use Glucose Monitors? Trend boosted by health buffs on social media, but benefit for healthy adults is unclear Aug 01, 2023
<乌鸦传媒>Kombucha Shows Potential Diabetes Benefit in Small Trial Diabetes patients saw glucose levels drop after drinking fermented tea Aug 01, 2023
<乌鸦传媒>Albuminuria Testing Falling Short in Patients at Risk for CKD If testing rates followed recommendations, some could start necessary meds sooner Jul 27, 2023
<乌鸦传媒>Aspartame Is a 'Possible' Carcinogen, WHO Declares But the organization's recommended limits on aspartame consumption remain unchanged Jul 13, 2023
<乌鸦传媒>Diabetes Projected to Affect 1.3 Billion People by 2050 Advance of disease driven by high BMI, with social determinants of health playing a role Jun 28, 2023
<乌鸦传媒>Protocol Optimizing Meds for T2D and CVD Pushed Beyond Cardiology Alone Endocrinologists urged to pay attention to COORDINATE trial Jun 27, 2023
<乌鸦传媒>Semaglutide Plus Cagrilintide Reduced Blood Sugar, Weight in T2D Once-weekly CagriSema reduced body weight more than either agent alone Jun 27, 2023
<乌鸦传媒>High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Loss Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose Jun 27, 2023
